Omega Diagnostics Group PLC Posting of Circular and Notice of General Meeting (4443L)
May 13 2022 - 5:05AM
UK Regulatory
TIDMODX
RNS Number : 4443L
Omega Diagnostics Group PLC
13 May 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Circular and Notice of General Meeting
Omega (AIM: ODX), the specialist medical diagnostics company
focused on industry-leading Health & Nutrition and Global
Health products, announces, further to the announcement of 6 May
2022, a Circular containing details of the Open Offer and convening
the General Meeting, together with a Form of Proxy will be posted
to Shareholders today.
The General Meeting will be held at the offices of Shepherd
& Wedderburn, 1 Exchange Crescent, Conference Square,
Edinburgh, EH3 8UL at 11.00 a.m. on 6 June 2022. A copy of the
Circular will today be made available on the Company's website:
http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Capitalised terms not otherwise defined in the text of this
announcement have the meanings given to them in the Company's
announcement dated 6 May 2022.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive via Walbrook PR
Officer
Chris Lea, Chief Financial
Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore
(Corporate Finance)
Alice Lane/ Harriet Ward
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro
diagnostic products for use in hospitals, clinics, laboratories and
healthcare practitioners in over 70 countries and specialise in the
areas of health and nutrition and global health.
www.omegadx.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOGEANSDFEEAEEA
(END) Dow Jones Newswires
May 13, 2022 05:05 ET (09:05 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Sep 2023 to Sep 2024